Difference between revisions of "User:Akulkarni"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "thumb|Amit A. Kulkarni M.B.B.S. Amit A. Kulkarni M.B.B.S. is a hematology/oncology fellow at the University of Minnesota in Minneapolis, Minnesota....")
 
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
 
[[File:Amit_Kulkarni.jpg|thumb|Amit A. Kulkarni M.B.B.S.]]
 
[[File:Amit_Kulkarni.jpg|thumb|Amit A. Kulkarni M.B.B.S.]]
Amit A. Kulkarni M.B.B.S. is a hematology/oncology fellow at the University of Minnesota in Minneapolis, Minnesota. After completing medical school in India, Amit completed a 3-year research fellowship in Mayo Clinic, Rochester, MN followed by a residency at Greater Baltimore Medical Center, Baltimore, MD. As a fellow, Amit's clinical and research interests are in thoracic oncology, microbiome and cancer, precision oncology, and clinical trials.
+
Amit A. Kulkarni M.B.B.S. is a thoracic oncologist at the University of Minnesota in Minneapolis, Minnesota. After completing medical school in India, Amit completed a 3-year research fellowship in Mayo Clinic, Rochester, MN followed by a Internal medicine residency at Greater Baltimore Medical Center, Baltimore, MD and Hematology-Oncology fellowship at University of Minnesota. Amit's clinical and research interests are immuno-oncology, targeted therapy, microbiome and cancer, and clinical trials.
 +
 
 +
He is the HemOnc.org Section Editor of [[:Category:Thoracic_cancers|Thoracic Oncology]].

Latest revision as of 00:26, 29 August 2023

Amit A. Kulkarni M.B.B.S.

Amit A. Kulkarni M.B.B.S. is a thoracic oncologist at the University of Minnesota in Minneapolis, Minnesota. After completing medical school in India, Amit completed a 3-year research fellowship in Mayo Clinic, Rochester, MN followed by a Internal medicine residency at Greater Baltimore Medical Center, Baltimore, MD and Hematology-Oncology fellowship at University of Minnesota. Amit's clinical and research interests are immuno-oncology, targeted therapy, microbiome and cancer, and clinical trials.

He is the HemOnc.org Section Editor of Thoracic Oncology.